skip to main content

S. 1821 (109th): Pandemic Preparedness and Response Act

We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

10/5/2005--Introduced. Pandemic Preparedness and Response Act - Amends the Public Health Service Act to require the President to appoint a National Director of Pandemic Preparedness and Response to strengthen, expand, and coordinate domestic pandemic influenza preparedness activities.

Establishes the Pandemic Influenza Preparedness Policy Coordinating Committee to develop an Interagency Preparedness Plan.

Requires states to have an approved state preparedness plan as a condition of receiving certain funds related to bioterrorism.

Provides for the integration and coordination of public and private influenza surveillance activities.

Directs the Secretary of Health and Human Services to: (1) procure antivirals, developed vaccines, and essential medications for the Strategic National Stockpile; (2) develop a national system for tracking and distributing antiviral medications and vaccines; and (3) assist other counties in preparation for, and response to, pandemic influenza.

Provides for the expansion and intensification of influenza research.

Directs the Secretary to contract with the Institute of Medicine to study topics related to the pandemic influenza.

Establishes the National Pandemic Influenza Economics Advisory Committee.

Requires the Secretary of Agriculture to expand and intensify efforts to prevent pandemic influenza.

Requires the Secretary of Health and Human Services to: (1) enter into contracts with manufacturers to produce additional necessary doses of the influenza vaccine; and (2) develop a national plan for responding to potential influenza vaccine shortages.

Sets forth prohibitions against charging excessive prices during a public health emergency for, reporting false pricing information to the Secretary about, or employing a manipulative or deceptive device or contrivance in connection with the purchase or sale of, drugs, devices, or biologics for the prevention or treatment of influenza at wholesale.